undamentalytics Newsletter
Sign in

Meiragtx Holdings plc income statement

In fiscal 2025, Meiragtx Holdings plc reported revenue of $81.4m, up 144.6% on the year before, operating income of −$106m (a -130.2% margin) and net income of −$114m, or −$1.42 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue13163816143381398
Research and development25346786104119130153
Selling and marketing—————245—
General and administrative4744444747545352
Operating income−58−63−73−116−137−164−106184
Interest expense000513131212
Income before tax−55−58−80−130−84−148−114—
Income tax000—0002
Net income−55−58−80−130−84−148−11479
Diluted EPS−$1.65−$1.54−$1.80−$2.87−$1.49−$2.12−$1.42$0.94
Diluted shares (average)33m38m44m45m56m70m80m84m
EBITDA−56−58−65−108−123−151−93196

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MGTX vs MNKDMGTX vs SVAMGTX vs NVAXMGTX vs PHAR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Meiragtx Holdings plc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Meiragtx Holdings plc.